A major specialty in South Korean clinics in 2026 is Pharmacopuncture (Yak-chim). This technique combines traditional acupuncture with modern pharmacology by injecting small amounts of purified herbal extracts directly into specific acupoints to enhance and prolong the therapeutic effect.

Commonly used extracts include "Bee Venom" (for its potent anti-inflammatory properties) and "Scolopendra" (centipede) extracts for neurological pain. In 2026, the production of these extracts is strictly regulated by the Ministry of Food and Drug Safety (MFDS) in specialized "G-GMP" (Good General Manufacturing Practice) facilities, ensuring that the botanical "drugs" are sterile and have a consistent concentration of active metabolites.